MELBOURNE: Sienna Cancer Diagnostics Ltd, a medical technology, announced the appointment of Aenorasis S.A as its exclusive distributor in Greece and Cyprus. The distribution agreement provides Aenorasis with the right to sell Sienna’s hTERT IVD to pathology laboratories where it will be used to assist in the diagnosis of bladder cancer. Aenorasis is a Greek…